Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HAA2
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 1 |
GO:0006457 | protein folding | 2 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018208 | peptidyl-proline modification | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0061077 | chaperone-mediated protein folding | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016853 | isomerase activity | 2 | 12 |
GO:0016859 | cis-trans isomerase activity | 3 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 292 | 296 | PF00656 | 0.564 |
CLV_C14_Caspase3-7 | 66 | 70 | PF00656 | 0.433 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.383 |
CLV_NRD_NRD_1 | 288 | 290 | PF00675 | 0.387 |
CLV_NRD_NRD_1 | 310 | 312 | PF00675 | 0.362 |
CLV_NRD_NRD_1 | 358 | 360 | PF00675 | 0.417 |
CLV_PCSK_KEX2_1 | 288 | 290 | PF00082 | 0.401 |
CLV_PCSK_KEX2_1 | 310 | 312 | PF00082 | 0.347 |
CLV_PCSK_PC1ET2_1 | 288 | 290 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 359 | 363 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 370 | 374 | PF00082 | 0.308 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 424 | 428 | PF00082 | 0.454 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.312 |
DOC_MAPK_gen_1 | 153 | 161 | PF00069 | 0.512 |
DOC_MAPK_gen_1 | 193 | 201 | PF00069 | 0.594 |
DOC_MAPK_gen_1 | 307 | 315 | PF00069 | 0.335 |
DOC_PP4_FxxP_1 | 247 | 250 | PF00568 | 0.459 |
DOC_USP7_MATH_1 | 248 | 252 | PF00917 | 0.440 |
DOC_USP7_UBL2_3 | 108 | 112 | PF12436 | 0.320 |
DOC_USP7_UBL2_3 | 409 | 413 | PF12436 | 0.362 |
DOC_USP7_UBL2_3 | 424 | 428 | PF12436 | 0.481 |
DOC_USP7_UBL2_3 | 94 | 98 | PF12436 | 0.320 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.314 |
DOC_WW_Pin1_4 | 121 | 126 | PF00397 | 0.271 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.565 |
LIG_14-3-3_CanoR_1 | 271 | 276 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 332 | 338 | PF00244 | 0.381 |
LIG_14-3-3_CanoR_1 | 348 | 357 | PF00244 | 0.384 |
LIG_Actin_WH2_2 | 96 | 114 | PF00022 | 0.354 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.671 |
LIG_BIR_III_2 | 242 | 246 | PF00653 | 0.532 |
LIG_BRCT_BRCA1_1 | 353 | 357 | PF00533 | 0.441 |
LIG_Clathr_ClatBox_1 | 135 | 139 | PF01394 | 0.331 |
LIG_EH1_1 | 61 | 69 | PF00400 | 0.369 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.270 |
LIG_FHA_1 | 142 | 148 | PF00498 | 0.449 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.401 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.400 |
LIG_FHA_1 | 367 | 373 | PF00498 | 0.441 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.403 |
LIG_FHA_2 | 10 | 16 | PF00498 | 0.641 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.388 |
LIG_Integrin_RGD_1 | 79 | 81 | PF01839 | 0.441 |
LIG_LIR_Apic_2 | 167 | 171 | PF02991 | 0.432 |
LIG_LIR_Apic_2 | 246 | 250 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 180 | 190 | PF02991 | 0.289 |
LIG_LIR_Gen_1 | 203 | 211 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 180 | 185 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 203 | 208 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 81 | 85 | PF02991 | 0.292 |
LIG_Pex14_2 | 427 | 431 | PF04695 | 0.581 |
LIG_PTB_Apo_2 | 167 | 174 | PF02174 | 0.524 |
LIG_SH2_CRK | 41 | 45 | PF00017 | 0.423 |
LIG_SH2_GRB2like | 168 | 171 | PF00017 | 0.462 |
LIG_SH2_NCK_1 | 168 | 172 | PF00017 | 0.419 |
LIG_SH2_PTP2 | 182 | 185 | PF00017 | 0.266 |
LIG_SH2_SRC | 117 | 120 | PF00017 | 0.441 |
LIG_SH2_SRC | 168 | 171 | PF00017 | 0.462 |
LIG_SH2_SRC | 182 | 185 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 63 | 66 | PF00017 | 0.312 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.171 |
LIG_SH3_3 | 123 | 129 | PF00018 | 0.297 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.513 |
LIG_SH3_3 | 28 | 34 | PF00018 | 0.447 |
LIG_SUMO_SIM_par_1 | 261 | 268 | PF11976 | 0.414 |
LIG_SUMO_SIM_par_1 | 393 | 399 | PF11976 | 0.358 |
LIG_SUMO_SIM_par_1 | 42 | 47 | PF11976 | 0.480 |
LIG_UBA3_1 | 158 | 163 | PF00899 | 0.517 |
LIG_UBA3_1 | 372 | 377 | PF00899 | 0.441 |
MOD_CDK_SPxK_1 | 194 | 200 | PF00069 | 0.572 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.391 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.473 |
MOD_CK1_1 | 267 | 273 | PF00069 | 0.580 |
MOD_CK1_1 | 394 | 400 | PF00069 | 0.222 |
MOD_CK1_1 | 8 | 14 | PF00069 | 0.638 |
MOD_GlcNHglycan | 148 | 152 | PF01048 | 0.450 |
MOD_GlcNHglycan | 251 | 254 | PF01048 | 0.463 |
MOD_GlcNHglycan | 291 | 294 | PF01048 | 0.562 |
MOD_GlcNHglycan | 353 | 356 | PF01048 | 0.511 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.707 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.475 |
MOD_GSK3_1 | 267 | 274 | PF00069 | 0.459 |
MOD_GSK3_1 | 351 | 358 | PF00069 | 0.395 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.649 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.306 |
MOD_N-GLC_1 | 130 | 135 | PF02516 | 0.297 |
MOD_N-GLC_1 | 366 | 371 | PF02516 | 0.445 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.568 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.328 |
MOD_NEK2_1 | 40 | 45 | PF00069 | 0.370 |
MOD_NEK2_1 | 5 | 10 | PF00069 | 0.794 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.391 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.211 |
MOD_NEK2_2 | 57 | 62 | PF00069 | 0.381 |
MOD_NEK2_2 | 99 | 104 | PF00069 | 0.331 |
MOD_PIKK_1 | 14 | 20 | PF00454 | 0.598 |
MOD_PIKK_1 | 48 | 54 | PF00454 | 0.483 |
MOD_PKA_1 | 289 | 295 | PF00069 | 0.457 |
MOD_PKA_2 | 333 | 339 | PF00069 | 0.351 |
MOD_Plk_1 | 130 | 136 | PF00069 | 0.297 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.374 |
MOD_Plk_1 | 173 | 179 | PF00069 | 0.372 |
MOD_Plk_1 | 258 | 264 | PF00069 | 0.457 |
MOD_Plk_1 | 267 | 273 | PF00069 | 0.434 |
MOD_Plk_1 | 83 | 89 | PF00069 | 0.321 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.312 |
MOD_Plk_4 | 153 | 159 | PF00069 | 0.385 |
MOD_Plk_4 | 258 | 264 | PF00069 | 0.369 |
MOD_Plk_4 | 391 | 397 | PF00069 | 0.272 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.376 |
MOD_Plk_4 | 422 | 428 | PF00069 | 0.569 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.433 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.314 |
MOD_ProDKin_1 | 121 | 127 | PF00069 | 0.271 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.560 |
MOD_SUMO_for_1 | 326 | 329 | PF00179 | 0.550 |
MOD_SUMO_for_1 | 412 | 415 | PF00179 | 0.317 |
MOD_SUMO_rev_2 | 276 | 284 | PF00179 | 0.391 |
TRG_ENDOCYTIC_2 | 182 | 185 | PF00928 | 0.336 |
TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.285 |
TRG_ER_diArg_1 | 309 | 311 | PF00400 | 0.347 |
TRG_ER_diArg_1 | 332 | 335 | PF00400 | 0.500 |
TRG_ER_diLys_1 | 428 | 432 | PF00400 | 0.547 |
TRG_NES_CRM1_1 | 22 | 37 | PF08389 | 0.353 |
TRG_NES_CRM1_1 | 387 | 399 | PF08389 | 0.311 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDU7 | Leptomonas seymouri | 76% | 100% |
A0A0S4IT01 | Bodo saltans | 46% | 100% |
A0A1X0P656 | Trypanosomatidae | 53% | 100% |
A0A3R7L7K6 | Trypanosoma rangeli | 55% | 100% |
A0A3S7WVP4 | Leishmania donovani | 87% | 100% |
A4HYI1 | Leishmania infantum | 87% | 100% |
D0A0V5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9ASA6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
P27124 | Oryctolagus cuniculus | 33% | 94% |
P30416 | Mus musculus | 33% | 94% |
Q02790 | Homo sapiens | 33% | 94% |
Q13451 | Homo sapiens | 30% | 95% |
Q38931 | Arabidopsis thaliana | 29% | 78% |
Q43207 | Triticum aestivum | 29% | 77% |
Q4QD56 | Leishmania major | 87% | 100% |
Q5RF88 | Pongo abelii | 30% | 95% |
Q64378 | Mus musculus | 30% | 95% |
Q7DMA9 | Arabidopsis thaliana | 25% | 68% |
Q8I4V8 | Plasmodium falciparum (isolate 3D7) | 24% | 100% |
Q95L05 | Chlorocebus aethiops | 30% | 95% |
Q9FJL3 | Arabidopsis thaliana | 29% | 75% |
Q9QVC8 | Rattus norvegicus | 33% | 94% |
Q9TRY0 | Bos taurus | 33% | 94% |
Q9VL78 | Drosophila melanogaster | 32% | 98% |
Q9XSH5 | Saimiri boliviensis boliviensis | 31% | 95% |
Q9XSI2 | Saguinus oedipus | 30% | 95% |
Q9XT11 | Aotus nancymaae | 30% | 95% |
V5AP12 | Trypanosoma cruzi | 50% | 90% |